AstraZeneca has been successful at rolling out its long-acting complement C5 inhibitor Ultomiris in the uses approved for its predecessor Soliris – until now, that is. The drugmaker confirmed this ...
Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL). The US regulator ...
How much do you know about your bones? If you're like most Americans, the answer is likely "not much." That's because understanding bone health often only becomes a priority after problems appear — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results